Thus, taken together, in concordance with the in vitro data, ICG-001 and VS-5584 synergize to reduce leukemic burden and prolong survival selectively in PRL-3 high AML xenografts in mice and warrant further clinical investigation. Here, PTP4A3 is linked to acute myeloid leukemia.